Medical News

RSS

Agensys and Seattle Genetics initiate ASG-5ME phase I clinical trial for castration-resistant prostate cancer

Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of castration-resistant prostate cancer. ASG-5ME is an antibody-drug conjugate (ADC) targeting the SLC44A4 antigen and is being co-developed by both companies for the treatment of solid tumors.

21 Oct 2010

Valensa enters agreement with Mercola for Flex Pro ES formulation

Valensa International and Mercola Health Resources, LLC announced today that they have entered into a license and supply agreement that provides Mercola Health Resources with Valensa's new Flex Pro ES(TM) joint health formulation.

21 Oct 2010

Menopausal estrogen replacement therapy speeds growth of ovarian cancer

Estrogen therapy used by menopausal women causes a type of ovarian cancer to grow five times faster, according to a new study by researchers at the University of Colorado Cancer Center.

21 Oct 2010

Cost of health plans rise, but health law only one reason

Most Ohioans will face higher health insurance premiums starting in January with hikes ranging from 8 percent to 18 percent giving rise to fresh complaints about the White House-backed health care law.

21 Oct 2010

Burn injuries in children show vitamin E depletion in fat tissues

Severe burn injuries in children have been shown to rapidly deplete the levels of vitamin E in their body's adipose, or fat tissues, a new clinical study has found.

21 Oct 2010

HHS did not violate federal law for Medicare ads, GAO says

The Hill Healthwatch: "The Department of Health and Human Services did not violate federal prohibitions on publicity and propaganda with its health reform advertising and technical assistance contracts, the Government Accountability Office said Tuesday. Two HHS television ads, however, 'overstate one of (the law's) benefits,' GAO writes in a letter to Reps. Dave Camp (R-Mich.) and Darrell Issa (R-Calif.). The lawmakers requested the office's legal opinion about the ads and HHS's contracts with MIT economist Jonathan Gruber.

21 Oct 2010

Access submits additional patent applications for Cobalamin-mediated oral drug delivery technology

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.

21 Oct 2010

Researchers to study effect of reovirus on cancer cells

A common virus that can cause coughing and mild diarrhea appears to have a major redemptive quality: the ability to kill cancer. Harnessing that power, researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, are conducting a clinical trial to see if the virus can target and kill certain tumor types.

21 Oct 2010

Aastrom submits SPA for Phase 3 clinical development program in critical limb ischemia to FDA

Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that it has submitted to the U.S. Food and Drug Administration (FDA) a special protocol assessment (SPA) describing the company's proposed Phase 3 clinical development program in critical limb ischemia (CLI).

21 Oct 2010

Kinemed updates translational biomarkers strategy at 2010 Conference in Boston

Marc K. Hellerstein, M.D., Ph.D. Co-Founder and Chief of SAB, Kinemed, Inc. presented an "Updated Strategy for Using Disease Predictive Translational Biomarkers in the Rapidly Advancing Field of Causal Pathway Measurements" at the 2010 Personalized and Translational Medicine Conference. In Boston, on September 20-21, 2010.

21 Oct 2010

Unitedhealth says it will test lump sum payments for some cancer care, reports earnings

Health insurer UnitedHealth said Tuesday that it will test a new way payment method for cancer doctors. The program pays doctors a lump sum payment for providing care during an entire course of care for the disease instead of how it's done now with a fee for each service a doctor provides.

21 Oct 2010

Generex announces participation in Annual Canadian Diabetes Association Conference

Generex Biotechnology Corporation today announced that it will be attending the 13th Annual Canadian Diabetes Association (CDA)/ Canadian Society of Endocrinology and Metabolism (CSEM)Professional Conference and Annual Meetings in Edmonton, Alberta. The gathering will run from October 20-23, 2010 at the Shaw Conference Centre.

21 Oct 2010

Study: p63 gene stifles spread of cancer

Long overshadowed by p53, its famous tumor-suppressing sibling, the p63 gene does the tougher, important job of stifling the spread of cancer to other organs, researchers at The University of Texas MD Anderson Cancer Center report in the Oct. 21 issue of Nature.

21 Oct 2010

C PORT Solutions releases new mobile computing platform for healthcare facilities

With the launch of MEDI PORT, C PORT Solutions is the world's first company to converge all forms of communication and collaboration with patient data, medical applications, and existing healthcare technologies so all healthcare professionals can diagnose or treat a patient with the highest level of care regardless of the healthcare professional's location.

21 Oct 2010

WorldHeart announces completion of private placement

World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has completed its previously announced private placement of common stock and warrants to purchase common stock. Gross proceeds from the offering were approximately $25.3 million. Proceeds from the private placement are expected to be used for general corporate and working capital purposes.

21 Oct 2010

CMS head Berwick praises new center for Medicare and Medicaid innovation

The planned Center for Medicare and Medicaid Innovation has the potential to be the 'jewel in the crown' of the Patient Protection and Affordable Care Act, Donald M. Berwick, administrator for the Centers for Medicare & Medicaid Services.

21 Oct 2010

VA checklists save lives, study says

The Associated Press: Going through a "surgery checklist" to confirm the basic procedures of a planned operation can help save lives, according to a study of 74 Veterans Affairs hospitals. In the hospitals being studied, "Surgery team members all created checklists and discussed them in briefings before, during and after surgery," reviewing basic information such as the reason for the surgery and the identity of the patient.

21 Oct 2010

DMC concludes Protege Phase 3 clinical trial for type 1 diabetes lacks efficacy

MacroGenics, Inc. and Eli Lilly and Company today announced that the Protege Data Monitoring Committee (DMC), composed of independent experts in the fields of diabetes and biostatistics, has completed a planned analysis of one-year safety and efficacy data of the Protege Phase 3 clinical trial of teplizumab, an investigational biologic under development for the treatment of individuals with recent-onset type 1 diabetes.

21 Oct 2010

Aqueous cream worsens eczema: Study

Researchers claim that a cream that is often used in a skin condition called eczema may actually make the condition worse. The research conducted at Bath University found that aqueous cream thinned the skin after a few weeks of use. They found that the cream contains a detergent rather than just moisturizers. The team also said that most GPs seemed unaware of official advice not to prescribe the cream as a moisturizer.

21 Oct 2010

NYU Langone Medical Center announces establishment of Smilow Comprehensive Prostate Cancer Center

NYU Langone Medical Center is pleased to announce that it has established The Smilow Comprehensive Prostate Cancer Center with a $5 million gift from Joel E. Smilow, a member of the Board of Trustees at NYU Langone Medical Center and New York University. The Smilow Center is dedicated to providing comprehensive, state-of-the-art personalized care for men with prostate cancer as well as educating men and their families about the disease and the wide range of treatment options available today.

21 Oct 2010

Medical News

Agensys and Seattle Genetics initiate ASG-5ME phase I clinical trial for castration-resistant prostate cancer

Valensa enters agreement with Mercola for Flex Pro ES formulation

Menopausal estrogen replacement therapy speeds growth of ovarian cancer

Cost of health plans rise, but health law only one reason

Burn injuries in children show vitamin E depletion in fat tissues

HHS did not violate federal law for Medicare ads, GAO says

Access submits additional patent applications for Cobalamin-mediated oral drug delivery technology

Researchers to study effect of reovirus on cancer cells

Aastrom submits SPA for Phase 3 clinical development program in critical limb ischemia to FDA

Kinemed updates translational biomarkers strategy at 2010 Conference in Boston

Unitedhealth says it will test lump sum payments for some cancer care, reports earnings

Generex announces participation in Annual Canadian Diabetes Association Conference

Study: p63 gene stifles spread of cancer

C PORT Solutions releases new mobile computing platform for healthcare facilities

WorldHeart announces completion of private placement

CMS head Berwick praises new center for Medicare and Medicaid innovation

VA checklists save lives, study says

DMC concludes Protege Phase 3 clinical trial for type 1 diabetes lacks efficacy

Aqueous cream worsens eczema: Study

NYU Langone Medical Center announces establishment of Smilow Comprehensive Prostate Cancer Center

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News